The Effect of Diabetes Mellitus on Costs and Length of Stay in Patients with Peripheral Arterial Disease Undergoing Vascular Surgery

被引:45
|
作者
Malone, M. [1 ,2 ]
Lau, N. S. [2 ,3 ]
White, J. [1 ,2 ]
Novak, A.
Xuan, W. [2 ]
Iliopoulos, J. [2 ,4 ]
Crozier, J. [2 ,4 ]
Dickson, H. G. [2 ,5 ]
机构
[1] Liverpool Hosp, High Risk Foot Serv, Liverpool, NSW 2170, Australia
[2] Ingham Inst Appl Med Res, LIVE DIAB CRU, Liverpool, NSW, Australia
[3] Liverpool Hosp, Diabet & Endocrine Serv, Liverpool, NSW 2170, Australia
[4] Western Hlth, Diabet Foot Serv, Melbourne, Vic, Australia
[5] Liverpool Hosp, Liverpool, NSW 2170, Australia
关键词
Diabetes mellitus; Economics; Length of stay; Lower limb; Peripheral arterial disease; Vascular surgery; PREVALENCE; CARE; HYPERGLYCEMIA;
D O I
10.1016/j.ejvs.2014.07.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To determine the impact of diabetes mellitus (DM) and other comorbidities on length of stay (LOS) and costs in patients with peripheral arterial disease (PAD) admitted to a vascular surgical unit. Methods: A retrospective study was conducted between January 2011 and July 2012 at a tertiary referral hospital in Sydney. Demographic, laboratory, and operative data were obtained from the Australasian Vascular Audit database and hospital diagnostic-related group (DRG) reports. Patients with confirmed PAD with or without DM requiring hospital admission for a diagnosis of claudication, rest pain, ulcer/gangrene, and infection that required lower limb surgical intervention were included. Associations between LOS, surgical procedure, and DRG were explored. Results: Five hundred and sixty-eight admissions (492 patients) were identified: 292 admissions with PAD and 276 admissions with PAD in conjunction with DM (PADDM). Mean LOS for patients with PAD was 10 +/- 13.7 days compared with 15 +/- 8.2 days for PADDM (p<.01; 95% confidence interval 2.7-8.0). LOS and costs were greatest in patients with PADDM undergoing major amputation (37 +/- 3.7 days; US$42,236; p<.01). Analysis of variance indicated that the best predictors of LOS were the presence of DM, bypass surgery, amputation, chronic kidney disease (CKD) stage V, infection, and emergency admission. Over 18 months, the estimated total inpatient costs associated with lower limb intervention for PAD with and without DM amounted to US$7,598,597. People with DM incurred greater inpatient costs, averaging US$1,912 more per episode of admission and a total of US$528,029 over 18 months. Conclusion: The impact of diabetes as a comorbid condition in patients with PAD is significant, both clinically and economically. Factors that predict increased LOS in patients with PAD are DM, bypass surgery, amputation, CKD stage V, infection, and emergency admission. (C) 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:447 / 451
页数:5
相关论文
共 50 条
  • [21] Reducing the length of stay for patients undergoing colorectal surgery
    Platell, Cameron F. E.
    ANZ JOURNAL OF SURGERY, 2009, 79 (09) : 579 - 580
  • [22] Reducing the length of stay for patients undergoing colorectal surgery
    Kahokehr, Arman A.
    Sammour, Tarik
    Srinivasa, Sanket
    Hill, Andrew G.
    ANZ JOURNAL OF SURGERY, 2010, 80 (03) : 195 - 195
  • [23] UNSUSPECTED DIABETES MELLITUS IN PERIPHERAL VASCULAR DISEASE
    BARTELS, CC
    RULLO, FR
    NEW ENGLAND JOURNAL OF MEDICINE, 1958, 259 (13): : 633 - 635
  • [24] Sarcopenia, peripheral neuropathy, and peripheral arterial disease in patients with diabetes mellitus under hemodialysis
    Bustamante Hernandez, Martha Beatriz
    Garduno Garcia, Jose de Jesus
    Montenegro Morales, Laura Patricia
    Camarillo Romero, Eneida del Socorro
    Huitron Bravo, Gerardo
    Camarillo Romero, Maria del Socorro
    REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2021, 41 (03): : 151 - 158
  • [25] Prognostic effect of peripheral vascular disease in patients undergoing coronary artery bypass graft surgery
    Esteban-Lucia, L.
    Nieto-Roca, L.
    Gonzalez-Lorenzo, O.
    Franco-Pelaez, J. A.
    Pello-Lazaro, A. M.
    Acena Navarro, A.
    Kallmeyer-Mayor, A. M.
    Venegas Rodriguez, A. M.
    Esteban-Chapel, J. A.
    Romero-Otero, J. M.
    Aldamiz Echevarria Del Castillo, G.
    Tunon, J.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1242 - 1242
  • [26] Length of stay and hospitalization costs for patients undergoing lung surgery with PROGEL pleural air leak sealant
    Mortman, Keith D.
    Corral, Mitra
    Zhang, Xiaohong
    Berhane, Indrias
    Soleas, Ireena M.
    Ferko, Nicole C.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (10) : 1016 - 1022
  • [27] Coronary artery revascularization before peripheral vascular surgery in patients with peripheral arterial disease
    Hideki Miyachi
    Jun Tanabe
    Eitaro Kodani
    Yusuke Hosokawa
    Mitsunobu Kitamura
    Asako Sasaki
    Michio Ogano
    Kunito Shiiba
    Hisato Takagi
    Takuya Umemoto
    Yoshiki Kusama
    Kyoichi Mizuno
    Cardiovascular Intervention and Therapeutics, 2010, 25 (1) : 11 - 17
  • [28] Coronary artery revascularization before peripheral vascular surgery in patients with peripheral arterial disease
    Miyachi, Hideki
    Tanabe, Jun
    Kodani, Eitaro
    Hosokawa, Yusuke
    Kitamura, Mitsunobu
    Sasaki, Asako
    Ogano, Michio
    Shiiba, K.
    Takagi, Hisato
    Umemoto, Takuya
    Kusama, Yoshiki
    Mizuno, Kyoichi
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2010, 25 (01) : 11 - 17
  • [29] Long-term outcomes of patients with diabetes mellitus undergoing percutaneous intervention for popliteal and infrapopliteal peripheral arterial disease
    Neupane, Saroj
    Edla, Sushruth
    Maidona, Eesha
    Sweet, Matthew C.
    Szpunar, Susan
    Davis, Thomas
    LaLonde, Thomas A.
    Mehta, Rajendra H.
    Rosman, Howard S.
    Yamasaki, Hiroshi
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (01) : 117 - 123
  • [30] The interrelationship between diabetes mellitus and peripheral arterial disease
    Stoberock, Konstanze
    Kaschwich, Mark
    Nicolay, Shiva Sophia
    Mahmoud, Nazeh
    Heidemann, Franziska
    Riess, Henrik C.
    Debus, Eike Sebastian
    Behrendt, Christian-Alexander
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2021, 50 (05) : 323 - 330